IP Library Granted Patent US 7,994,320
Granted Patent B2
US 7,994,320 · App. 12/208,191 · Granted Aug 9, 2011

Narcistatin prodrugs

Assignee: Arizona Board of Regents, a Body Corporate of the State of Arizona, Acting for and on behalf of Arizona State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,994,320
App. No.
12/208,191
Granted
Aug 9, 2011
Kind
B2
Abstract

The present invention provides prodrugs derived from the sparingly soluble anticancer isocarbostyril narciclasine, a component of various Narcissus species, said prodrugs having potential for use against animal and human cancers. Also disclosed is an efficient procedure for the synthetic conversion of narciclasine to several more soluble cyclic phosphate compounds, including “narcistatin”.

Claims (34)

1. A method for synthesizing pyridinium narcistatin, comprising reacting:

narciclasine;

tetrabutylammonium dihydrogen phosphate;

dicyclohexylcarbodiimide; and

p-toluenesulfonic acid in pyridine, to form a reaction mixture and forming pyridinium narcistatin.

2. The method of claim 1 , further comprising heating the reaction mixture to cause precipitation of pyridinium narcistatin.

3. A method for synthesizing pyridinium narcistatin, comprising reacting

narciclasine;

tetrabutylammonium dihydrogen phosphate; and

dicyclohexylcarbodiimide in pyridine, to form a reaction mixture and forming pyridinium narcistatin.

4. The method of claim 3 , further comprising heating the reaction mixture to cause precipitation of pyridinium narcistatin.

5. A method for synthesizing a compound having the formula:

wherein Z is a H + or a metal cation,

comprising reacting:

narciclasine;

tetrabutylammonium dihydrogen phosphate;

dicyclohexylcarbodiimide; and

p-toluenesulfonic acid in pyridine, to form a reaction mixture and forming pyridinium narcistatin;

forming a solution of pyridinium narcistatin; and

passing the solution of pyridinium narcistatin through a cation exchange resin,

wherein the resin is a hydrogen form or bears a metal cation, to form the compound.

6. The method of claim 5 , wherein Z is a metal cation selected from the group consisting of Li, Na, K or Cs.

7. The method of claim 6 , wherein Z is Na.

8. A method for synthesizing a compound having the formula:

wherein Z is a metal cation,

comprising reacting:

narciclasine;

tetrabutylammonium dihydrogen phosphate;

dicyclohexylcarbodiimide; and

p-toluenesulfonic acid in pyridine, to form a reaction mixture and forming pyridinium narcistatin;

suspending the pyridinium narcistatin in solvent; and

reacting with a metal acetate, to form the compound.

9. The method of claim 8 , wherein the metal acetate is selected from the group consisting of acetates of Mg, Ca, Zn and Mn.

10. The method of claim 9 , wherein the solvent in which the pyridinium narcistatin is suspended is comprised of methanol and water.

Assignments (4)
CONFIRMATORY LICENSE Recorded Dec 30, 2019
From: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 051385/0344 →
CONFIRMATORY LICENSE Recorded Sep 30, 2019
From: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 050570/0441 →
CONFIRMATORY LICENSE Recorded Jan 19, 2017
From: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041417/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2008
From: PETTIT, GEORGE R.; MELODY, NOELEEN
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 021581/0741 →
Continuity (3)
Continuation 10537968
Provisional Application 60432219 · Dec 9, 2002
Related Publication 20090082569A1 · Mar 26, 2009